15 August 2025 : Clinical Research
Comparative Analysis of Hemodiafiltration Methods: Efficacy and Safety in Maintenance Hemodialysis
Zhuojia Xu ABCDEFG 1*, Dongdong Wang ABCDEF 1, Kai Wang BCDE 1, Guoyu Liang BCDE 1DOI: 10.12659/MSM.948227
Med Sci Monit 2025; 31:e948227
Table 3 Primary outcome analysis: dialysate removal amount of β2-microglobulin (β2-MG) and α1-microglobulin (α1-MG) according to the 5 hemodiafiltration modalities.
| Variable (unit) | T1 | T2 | T3 | T4 | T5 |
|---|---|---|---|---|---|
| β2-MG (mg) | 193.31±50.07b | 239.4±70.05a | 233.72±60.59a | 231.48±57.09a | 234.91±70.65a |
| α1-MG (mg) | 20.57±7.26b | 70.46±28.48a | 39.46±18.77a | 35.55±18.62a | 54.87±33.49a |
| Data are expressed as mean±standard deviation. All analyses were conducted using the Kruskal-Wallis non-parametric test. a b c d 0.05 vs T4; e | |||||